Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved silencing properties using small internally segmented interfering RNAs.

Jesper B Bramsen1, Maria B Laursen, Christian K Damgaard

  • 1Department of Molecular Biology, University of Aarhus, DK-8000, Aarhus C, Denmark.

Nucleic Acids Research
|August 30, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-gene oligonucleotides targeting Friedreich's ataxia expanded GAA⋅TTC repeats increase Frataxin expression.

Molecular therapy. Nucleic acids·2025
Same author

Proteomics of colorectal tumors identifies the role of CAVIN1 in tumor relapse.

Molecular systems biology·2025
Same author

Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate the phenotype in <i>BTK</i>/<i>Tec</i> double deficient X-linked agammaglobulinemia model.

RSC chemical biology·2025
Same author

Engineered PepFect14 analog for efficient cellular delivery of oligonucleotides.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

Anti-gene oligonucleotide clamps invade dsDNA and downregulate <i>huntingtin</i> expression.

Molecular therapy. Nucleic acids·2025
Same author

Exploring the biology of ctDNA release in colorectal cancer.

European journal of cancer (Oxford, England : 1990)·2024
Same journal

Correction to 'scSuperAnnotator: A platform for benchmarking comparison and visualizing automated cellular annotation methods for scRNA-seq data'.

Nucleic acids research·2026
Same journal

Correction to 'Differentiable partition function calculation for RNA'.

Nucleic acids research·2026
Same journal

Deployment of non-canonical splicing in tunicate genomes is mediated by divergent U2AF function and changing m6A modification in U1 and U6 snRNA.

Nucleic acids research·2026
Same journal

Bacillus subtilis DnaB forms multiple protein-protein interactions essential for DNA replication initiation.

Nucleic acids research·2026
Same journal

Multiple forms of protein-protein and DNA binding are exhibited by BrxC from the BREX phage restriction system.

Nucleic acids research·2026
Same journal

Biosynthesis of glycosylated 5-hydroxycytosine in the DNA of diverse viruses.

Nucleic acids research·2026
See all related articles

A new small internally segmented interfering RNA (sisiRNA) design enhances RNA interference functionality. This novel approach eliminates unintended targeting and improves in vivo properties for therapeutic applications.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • RNA interference (RNAi) is a gene silencing mechanism mediated by small interfering RNAs (siRNAs).
  • Standard siRNAs typically have a 19-27 base pair double-stranded region crucial for RISC incorporation.
  • Unintended targeting by sense strands in standard siRNAs can limit therapeutic efficacy.

Purpose of the Study:

  • To introduce and characterize a novel three-stranded siRNA construct, termed small internally segmented interfering RNA (sisiRNA).
  • To evaluate the functionality and specificity of the sisiRNA design in RNA interference.
  • To assess the potential of sisiRNA to improve the in vivo pharmacokinetic properties of RNAi therapeutics.

Main Methods:

  • Design and synthesis of the three-stranded sisiRNA construct.

Related Experiment Videos

  • Incorporation of sisiRNA into the RNA-induced silencing complex (RISC).
  • Assessment of mRNA targeting and degradation mediated by sisiRNA.
  • Evaluation of chemical modification compatibility and in vivo properties.

    • Main Results:

    • The novel sisiRNA design is highly functional, demonstrating RNA interference without a contiguous double-stranded region.
    • Only the antisense strand of sisiRNA is functional in activated RISC, eliminating off-target effects from the sense strand.
    • The sisiRNA design accommodates chemically modified antisense strands, which are ineffective in standard siRNA designs.
    • sisiRNA shows potential for improved in vivo pharmacokinetic properties.

    Conclusions:

    • An intact sense strand is not required for functional RNA interference.
    • The sisiRNA design offers enhanced specificity by preventing sense-strand-mediated off-target effects.
    • sisiRNA technology holds promise for developing more effective and safer RNAi-based therapeutics with improved delivery characteristics.